
Alberto Santagostino
Description
Alberto Santagostino is a Head of Gene and Cell Therapy at Lonza.
Investor Profile
Alberto Santagostino has made 1 investments, with 1 in the past 12 months and 0% as lead.
Stage Focus
- Seed (100%)
Industry Focus
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.